Insider Purchases Worth CN¥5.34m See Losses As Shanghai Bao Pharmaceuticals Market Value Drops To HK$5.6b

Simply Wall St.07-18

Insiders who acquired CN¥5.34m worth of Shanghai Bao Pharmaceuticals Co., Ltd.'s (HKG:2659) stock at an average price of CN¥21.36 in the past 12 months may be dismayed by the recent 13% price decline....

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2652975236?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","is_english":true,"pubTime":"2026-07-18 08:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2652975236","market":"hk","top_or_hot":-1,"title":"Insider Purchases Worth CN¥5.34m See Losses As Shanghai Bao Pharmaceuticals Market Value Drops To HK$5.6b","media":"Simply Wall St.","content":"<div>\n<p>Insiders who acquired CN¥5.34m worth of Shanghai Bao Pharmaceuticals Co., Ltd.'s (HKG:2659) stock at an average price of CN¥21.36 in the past 12 months may be dismayed by the recent 13% price decline....</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2659/shanghai-bao-pharmaceuticals-shares/news/insider-purchases-worth-cn534m-see-losses-as-shanghai-bao-ph\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insider Purchases Worth CN¥5.34m See Losses As Shanghai Bao Pharmaceuticals Market Value Drops To HK$5.6b</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsider Purchases Worth CN¥5.34m See Losses As Shanghai Bao Pharmaceuticals Market Value Drops To HK$5.6b\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-18 08:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2659/shanghai-bao-pharmaceuticals-shares/news/insider-purchases-worth-cn534m-see-losses-as-shanghai-bao-ph><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Insiders who acquired CN¥5.34m worth of Shanghai Bao Pharmaceuticals Co., Ltd.'s (HKG:2659) stock at an average price of CN¥21.36 in the past 12 months may be dismayed by the recent 13% price decline....</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2659/shanghai-bao-pharmaceuticals-shares/news/insider-purchases-worth-cn534m-see-losses-as-shanghai-bao-ph\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CN","symbol_name":"Xtrackers MSCI All China Equity ETF","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2659/shanghai-bao-pharmaceuticals-shares/news/insider-purchases-worth-cn534m-see-losses-as-shanghai-bao-ph","article_id":"2652975236","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2659/shanghai-bao-pharmaceuticals-shares/news/insider-purchases-worth-cn534m-see-losses-as-shanghai-bao-ph","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2652975236","pubTimestamp":1784335887,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Insiders who acquired CN¥5.34m worth of Shanghai Bao Pharmaceuticals Co., Ltd.'s ( HKG:2659 ) stock at an average price...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"CN":"Xtrackers MSCI All China Equity ETF","02659":"宝济药业-B","BK1161":"生物科技"},"translate_title":"上海宝医药市值跌至 5.6b 港元，内幕人士购买价值 534 万人民币，出现亏损","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1,"CN":1.5},"content_text":"Insiders who acquired CN¥5.34m worth of Shanghai Bao Pharmaceuticals Co., Ltd.'s (HKG:2659) stock at an average price of CN¥21.36 in the past 12 months may be dismayed by the recent 13% price decline.  Insiders purchase with the hope of seeing their investments increase in value over time. However, due to recent losses, their initial investment is now only worth CN¥4.33m, which is not great.     While insider transactions are not the most important thing when it comes to long-term investing,  logic dictates you should pay some attention to whether insiders are buying or selling shares.  We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.Advertisement The Last 12 Months Of Insider Transactions At Shanghai Bao Pharmaceuticals   In the last twelve months, the biggest single purchase by an insider was when Co-Founder & Executive Chairman Liu Yanjun bought HK$3.6m worth of shares at a price of HK$24.33 per share.    That means that an insider was happy to buy shares at above the current price of HK$17.33.  It's very possible they regret the purchase, but it's more likely they are bullish about the company.  We always take careful note of the price insiders pay when purchasing shares.   Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price.  Liu Yanjun was the only individual insider to buy shares in the last twelve months.       Liu Yanjun purchased 250.00k shares over the year. The average price per share was HK$21.36.   You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below.  By clicking on the graph below, you can see the precise details of each insider transaction!  View our latest analysis for Shanghai Bao Pharmaceuticals SEHK:2659 Insider Trading Volume July 18th 2026 Shanghai Bao Pharmaceuticals is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations,  this free list of growing companies with recent insider purchasing, could be just the ticket.  Insider Ownership Of Shanghai Bao Pharmaceuticals  For a common shareholder, it is worth checking how many shares are held by company insiders.  Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term.   Shanghai Bao Pharmaceuticals insiders own about HK$2.1b worth of shares (which is 37% of the company).  This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.   What Might The Insider Transactions At Shanghai Bao Pharmaceuticals Tell Us?  It's certainly positive to see the recent insider purchase.    And the longer term insider transactions also give us confidence.   However, we note that the company didn't make a profit over the last twelve months, which makes us cautious.     When combined with notable insider ownership, these factors suggest Shanghai Bao Pharmaceuticals insiders are well aligned, and quite possibly think the share price is too low.  Looks promising!      While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision.     While conducting our analysis, we found that Shanghai Bao Pharmaceuticals has 1 warning sign and it would be unwise to ignore it.   Of course Shanghai Bao Pharmaceuticals may not be the best stock to buy. So you may wish to see this free collection of high quality companies. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2652975236","isCrawlerRequest":true}